A Bacterial Effector Mimics a Host HSP90 Client to Undermine Immunity.
Lopez VA, Park BC, Nowak D, Sreelatha A, Zembek P, Fernandez J, Servage KA, Gradowski M, Hennig J, Tomchick DR, Pawlowski K, Krzymowska M, Tagliabracci VS, 2019 Sep Cell 1 179 205-218.e21Protein AMPylation by an Evolutionarily Conserved Pseudokinase.
Sreelatha A, Yee SS, Lopez VA, Park BC, Kinch LN, Pilch S, Servage KA, Zhang J, Jiou J, Karasiewicz-Urbanska M, Lobocka M, Grishin NV, Orth K, Kucharczyk R, Pawlowski K, Tomchick DR, Tagliabracci VS, 2018 10 Cell 3 175 809-821.e19Phosphorylation of spore coat proteins by a family of atypical protein kinases.
Nguyen KB, Sreelatha A, Durrant ES, Lopez-Garrido J, Muszewska A, Dudkiewicz M, Grynberg M, Yee S, Pogliano K, Tomchick DR, Pawlowski K, Dixon JE, Tagliabracci VS, 2016 06 Proc. Natl. Acad. Sci. U.S.A. 25 113 E3482-91Vibrio effector protein VopQ inhibits fusion of V-ATPase-containing membranes.
Sreelatha A, Bennett TL, Carpinone EM, O'Brien KM, Jordan KD, Burdette DL, Orth K, Starai VJ, 2015 Jan Proc. Natl. Acad. Sci. U.S.A. 1 112 100-5The pore-forming bacterial effector, VopQ, halts autophagic turnover.
Sreelatha A, Orth K, Starai VJ, 2013 Dec Autophagy 12 9 2169-70